← Leaderboards
Robert Jordan
Viropharma, Inc.
$8,294,647
Attributed
$8,294,647
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–08$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
Funding mix
By agency
NIH$8,294,647 · 2
By mechanism
R44$8,006,854 · 1
R43$287,793 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antiviral Agents”
- Constance Ann Benson · University Of California, San Diego$209,152,068
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$120,325,769
- Judith S. Currier · University Of California Los Angeles$102,391,456
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Sharon A Nachman · Johns Hopkins University$77,262,665
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
Research focus
Antiviral AgentsVirus ReplicationDrug ResistanceAnalogAnimal ModelBioavailableBiologicalBiochemical GeneticsDesignBioterrorism /Chemical WarfareBaseChemical StructureClinical ResearchClinical TrialsCultured CellsCowpoxCytotoxicDailyBiochemicalDisease ModelDoseDouble-Blind Placebo Controlled TrialBiothreatAnimals
Grant awards (5)
Small Molecule Inhibitors of Smallpox Virus Replication$1,829,082
R44 · FY2008 · AI · contact PI
Small Molecule Inhibitors of Smallpox Virus Replication$1,751,533
R44 · FY2007 · AI · contact PI
Small Molecule Inhibitors of Smallpox Virus Replication$1,513,613
R44 · FY2006 · AI · contact PI
Small Molecule Inhibitors of Smallpox Virus Replication$2,912,626
R44 · FY2005 · AI
Small Molecule Inhibitors of Smallpox Virus Replication$287,793
R43 · FY2003 · AI